Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
J Cardiovasc Magn Reson ; 17: 91, 2015 Oct 31.
Article in English | MEDLINE | ID: mdl-26520571

ABSTRACT

BACKGROUND: The aim of the current study was to examine whether the use of highly active antiretroviral therapy (HAART) in patients with HIV is associated with changes in pericardial fat and myocardial lipid content measured by cardiovascular magnetic resonance (CMR). METHODS: In this prospective case-control study, we compared 27 HIV seropositive (+) male subjects receiving HAART to 22 control male subjects without HIV matched for age, ethnicity and body mass index. All participants underwent CMR imaging for determination of pericardial fat [as volume at the level of the origin of the left main coronary artery (LM) and at the right ventricular free wall] and magnetic resonance spectroscopy (MRS) for evaluation of intramyocardial lipid content (% of fat to water in a single voxel at the interventricular septum). All measurements were made by two experienced readers blinded to the clinical history of the study participants. Two-sample t-test, Spearman's correlation coefficient or Pearson's correlation coefficient and multivariable logistic regression were used for statistical analysis. RESULTS: Pericardial fat volume at the level of LM origin was higher in HIV (+) subjects (33.4 cm(3) vs. 27.4 cm(3), p = 0.03). On multivariable analysis adjusted for age, Framingham risk score (FRS) and waist/hip ratio, pericardial fat remained significantly associated to HIV-status (OR 1.09, p = 0.047). For both HIV (+) and HIV (-) subjects, pericardial fat volume showed strong correlation with intramyocardial lipid content (r = 0.58, p < 0.0001) and FRS (r = 0.53, p = 0.0002). Among HIV (+) subjects, pericardial fat was significantly higher in patients with lipo-accumulation (37 cm(3) vs. 27.1 cm(3), p = 0.03) and showed significant correlation with duration of both HIV infection (r = 0.5, p = 0.01) and HAART (r = 0.46, p = 0.02). CONCLUSIONS: Pericardial fat content is increased in HIV (+) subjects on chronic HAART (>5 years), who demonstrate HAART-related lipo-accumulation and prolonged HIV duration of infection. Further investigation is warranted to determine whether increased pericardial fat is associated with higher cardiovascular risk leading to premature cardiovascular events in this patient population.


Subject(s)
Adipose Tissue/drug effects , Adiposity/drug effects , Anti-HIV Agents/adverse effects , HIV Infections/drug therapy , Lipid Metabolism/drug effects , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Myocardium/metabolism , Pericardium/drug effects , Adipose Tissue/metabolism , Adipose Tissue/pathology , Adult , Anti-HIV Agents/administration & dosage , Antiretroviral Therapy, Highly Active/adverse effects , Case-Control Studies , Drug Administration Schedule , Feasibility Studies , HIV Infections/diagnosis , HIV Infections/metabolism , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Myocardium/pathology , Odds Ratio , Pericardium/metabolism , Pericardium/pathology , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Risk Factors , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL